Patent · US Active

Compositions comprising physiologic concentrations of cytokines

US8088732B2 · kind B2 · utility

21Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2010
Grant dateJan 3, 2012
Priority date
Expiry dateFeb 3, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to novel cellular factor-containing solution compositions (referred to herein as “CFS” compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as “SR-CFS” compositions), methods of making such novel compositions and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.